Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma

OncoMed Pharmaceuticals, Inc. · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
pancreatic-cancer
pancreatic cancer, 1st-line metastatic pancreatic ductal adenocarcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 873865
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.